(Q46845154)

25 December 2017

title

Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells (English)

1 reference

25 December 2017

chronic lymphocytic leukemia

0 references

0 references

1 reference

1 reference

Spaner DE

1

1 reference

25 December 2017

Shi Y

2

1 reference

25 December 2017

White D

3

1 reference

25 December 2017

Mena J

4

1 reference

25 December 2017

Hammond C

5

1 reference

25 December 2017

Tomic J

6

1 reference

25 December 2017

He L

7

1 reference

25 December 2017

Tomai MA

8

1 reference

25 December 2017

Miller RL

9

1 reference

25 December 2017

Booth J

10

1 reference

25 December 2017

Radvanyi L

11

1 reference

25 December 2017

publication date

1 February 2006

1 reference

25 December 2017

published in

Leukemia

1 reference

25 December 2017

volume

20

1 reference

25 December 2017

page(s)

286-295

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404061

exact match

0 references

cites work

A phase I/II trial of oxidized autologous tumor vaccines during the "watch and wait" phase of chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Immunity against solid tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Pathogen recognition with Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Regression of lymphomatous skin deposits in a chronic lymphocytic leukemia patient treated with the Toll-like receptor-7/8 agonist, imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

A new method for detecting TNF-alpha-secreting cells using direct-immunofluorescence surface membrane stainings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

p38 mitogen-activated protein kinase inhibitors--mechanisms and therapeutic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Inactivation of Stat3 in tumor cells: releasing a brake on immune responses against cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Molecular mechanisms of endotoxin tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

Loxoribine affects fludarabine activity on freshly isolated B-chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404061

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.LEU.2404061

1 reference

25 December 2017

release_m6epluvtorblvjlcyz2lzbijd4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/m6epluvtorblvjlcyz2lzbijd4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16341037

1 reference

25 December 2017